★ ANNUAL REVIEW 2027 SPONSORSHIPS NOW OPEN   Learn more →

Log In  |  Become a Member  |  Sponsor  |  ⌕ Search

News/Cyber & Privacy/European Commission Issues Updated Q&A on Interplay between the GDPR and the Clinical Trials Regulation
Expert Opinion·Cyber & Privacy Brief

European Commission Issues Updated Q&A on Interplay between the GDPR and the Clinical Trials Regulation

On April 10, 2019, European Commission Directorate-General for Health and Food Safety issued a revised Q&A analyzing the interplay between the EU Clinical Trials Regulation (“CTR”) and the  EU General Data Protection Regulation (“GDPR”).  The revised Q&A takes into account the opinion of the European Data Protection Board (“EDPB”) issued on January 23, 2019, on the same topic (which we discuss in our blog post here).  Below, we summarize the main takeaways of the Commission’s updated Q&A.

🔒 Members Only · Cyber & Privacy BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every case digest, six days a week.
Not ready to join? Take the free Pub K Weekly digest.One email. Free. Top industry articles, the community calendar, and the latest job postings.